nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—Cytochrome P450 2D6 Inhibitors—Clobazam—epilepsy syndrome	0.474	1	CiPCiCtD
Mirabegron—SLCO1A2—epilepsy syndrome	0.113	0.486	CbGaD
Mirabegron—BCHE—epilepsy syndrome	0.0508	0.218	CbGaD
Mirabegron—CYP2D6—epilepsy syndrome	0.0279	0.12	CbGaD
Mirabegron—ALB—epilepsy syndrome	0.0208	0.0897	CbGaD
Mirabegron—ABCB1—epilepsy syndrome	0.0199	0.0856	CbGaD
Mirabegron—ALB—Oxcarbazepine—epilepsy syndrome	0.017	0.0874	CbGbCtD
Mirabegron—ALB—Fosphenytoin—epilepsy syndrome	0.0148	0.0764	CbGbCtD
Mirabegron—ALB—Clonazepam—epilepsy syndrome	0.0134	0.0691	CbGbCtD
Mirabegron—ALB—Rufinamide—epilepsy syndrome	0.0109	0.0563	CbGbCtD
Mirabegron—ABCB1—Levetiracetam—epilepsy syndrome	0.0097	0.05	CbGbCtD
Mirabegron—ALB—Phenytoin—epilepsy syndrome	0.00956	0.0492	CbGbCtD
Mirabegron—ALB—Propofol—epilepsy syndrome	0.00891	0.0459	CbGbCtD
Mirabegron—ALB—Diazepam—epilepsy syndrome	0.00807	0.0416	CbGbCtD
Mirabegron—ABCB1—Clobazam—epilepsy syndrome	0.00673	0.0346	CbGbCtD
Mirabegron—ABCB1—Lamotrigine—epilepsy syndrome	0.00647	0.0333	CbGbCtD
Mirabegron—ABCB1—Carbamazepine—epilepsy syndrome	0.00557	0.0287	CbGbCtD
Mirabegron—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00532	0.0274	CbGbCtD
Mirabegron—ABCB1—Phenytoin—epilepsy syndrome	0.005	0.0257	CbGbCtD
Mirabegron—CYP3A4—Felbamate—epilepsy syndrome	0.00494	0.0255	CbGbCtD
Mirabegron—CYP3A4—Trimethadione—epilepsy syndrome	0.00494	0.0255	CbGbCtD
Mirabegron—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00465	0.0239	CbGbCtD
Mirabegron—ABCB1—Phenobarbital—epilepsy syndrome	0.00446	0.0229	CbGbCtD
Mirabegron—ABCB1—Midazolam—epilepsy syndrome	0.00439	0.0226	CbGbCtD
Mirabegron—CYP2D6—Propofol—epilepsy syndrome	0.00439	0.0226	CbGbCtD
Mirabegron—ABCB1—Diazepam—epilepsy syndrome	0.00422	0.0218	CbGbCtD
Mirabegron—CYP3A4—Clonazepam—epilepsy syndrome	0.0042	0.0217	CbGbCtD
Mirabegron—CYP3A4—Clobazam—epilepsy syndrome	0.00403	0.0208	CbGbCtD
Mirabegron—CYP3A4—Rufinamide—epilepsy syndrome	0.00343	0.0176	CbGbCtD
Mirabegron—CYP3A4—Carbamazepine—epilepsy syndrome	0.00334	0.0172	CbGbCtD
Mirabegron—CYP3A4—Primidone—epilepsy syndrome	0.00312	0.0161	CbGbCtD
Mirabegron—CYP3A4—Phenytoin—epilepsy syndrome	0.003	0.0154	CbGbCtD
Mirabegron—CYP3A4—Propofol—epilepsy syndrome	0.00279	0.0144	CbGbCtD
Mirabegron—CYP3A4—Phenobarbital—epilepsy syndrome	0.00267	0.0138	CbGbCtD
Mirabegron—CYP3A4—Acetazolamide—epilepsy syndrome	0.00267	0.0138	CbGbCtD
Mirabegron—CYP3A4—Midazolam—epilepsy syndrome	0.00263	0.0136	CbGbCtD
Mirabegron—CYP3A4—Diazepam—epilepsy syndrome	0.00253	0.013	CbGbCtD
Mirabegron—CYP3A4—Zonisamide—epilepsy syndrome	0.00247	0.0127	CbGbCtD
Mirabegron—CYP3A4—Valproic Acid—epilepsy syndrome	0.00199	0.0103	CbGbCtD
Mirabegron—CYP3A4—Topiramate—epilepsy syndrome	0.0018	0.00927	CbGbCtD
Mirabegron—SLCO1A2—forebrain—epilepsy syndrome	8.48e-05	0.0494	CbGeAlD
Mirabegron—SLCO1A2—telencephalon—epilepsy syndrome	7.8e-05	0.0454	CbGeAlD
Mirabegron—CYP2D6—hindbrain—epilepsy syndrome	7.14e-05	0.0416	CbGeAlD
Mirabegron—ORM1—spinal cord—epilepsy syndrome	6.2e-05	0.0361	CbGeAlD
Mirabegron—BCHE—brainstem—epilepsy syndrome	6.18e-05	0.0359	CbGeAlD
Mirabegron—Labetalol—CYP2D6—epilepsy syndrome	6.16e-05	0.433	CrCbGaD
Mirabegron—SLCO1A2—medulla oblongata—epilepsy syndrome	6.13e-05	0.0357	CbGeAlD
Mirabegron—BCHE—forebrain—epilepsy syndrome	5.96e-05	0.0347	CbGeAlD
Mirabegron—SLCO1A2—midbrain—epilepsy syndrome	5.6e-05	0.0326	CbGeAlD
Mirabegron—BCHE—telencephalon—epilepsy syndrome	5.48e-05	0.0319	CbGeAlD
Mirabegron—SLCO1A2—spinal cord—epilepsy syndrome	5.46e-05	0.0318	CbGeAlD
Mirabegron—Asthenia—Levetiracetam—epilepsy syndrome	5.42e-05	0.000784	CcSEcCtD
Mirabegron—Pruritus—Midazolam—epilepsy syndrome	5.41e-05	0.000783	CcSEcCtD
Mirabegron—Constipation—Oxcarbazepine—epilepsy syndrome	5.4e-05	0.000781	CcSEcCtD
Mirabegron—Urticaria—Felbamate—epilepsy syndrome	5.38e-05	0.000778	CcSEcCtD
Mirabegron—Vision blurred—Valproic Acid—epilepsy syndrome	5.37e-05	0.000777	CcSEcCtD
Mirabegron—Urinary tract disorder—Gabapentin—epilepsy syndrome	5.36e-05	0.000775	CcSEcCtD
Mirabegron—Abdominal pain—Felbamate—epilepsy syndrome	5.35e-05	0.000774	CcSEcCtD
Mirabegron—Diarrhoea—Propofol—epilepsy syndrome	5.35e-05	0.000774	CcSEcCtD
Mirabegron—Pruritus—Levetiracetam—epilepsy syndrome	5.35e-05	0.000773	CcSEcCtD
Mirabegron—Connective tissue disorder—Gabapentin—epilepsy syndrome	5.33e-05	0.000772	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	5.33e-05	0.000772	CcSEcCtD
Mirabegron—Dyspepsia—Carbamazepine—epilepsy syndrome	5.33e-05	0.000771	CcSEcCtD
Mirabegron—Urethral disorder—Gabapentin—epilepsy syndrome	5.32e-05	0.00077	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Topiramate—epilepsy syndrome	5.3e-05	0.000767	CcSEcCtD
Mirabegron—Headache—Acetazolamide—epilepsy syndrome	5.27e-05	0.000763	CcSEcCtD
Mirabegron—Urticaria—Zonisamide—epilepsy syndrome	5.27e-05	0.000762	CcSEcCtD
Mirabegron—Abdominal pain—Zonisamide—epilepsy syndrome	5.24e-05	0.000758	CcSEcCtD
Mirabegron—Asthenia—Fosphenytoin—epilepsy syndrome	5.23e-05	0.000757	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	5.23e-05	0.000756	CcSEcCtD
Mirabegron—Gastrointestinal pain—Clonazepam—epilepsy syndrome	5.22e-05	0.000756	CcSEcCtD
Mirabegron—Fatigue—Carbamazepine—epilepsy syndrome	5.22e-05	0.000755	CcSEcCtD
Mirabegron—ORM1—nervous system—epilepsy syndrome	5.22e-05	0.0304	CbGeAlD
Mirabegron—Constipation—Carbamazepine—epilepsy syndrome	5.18e-05	0.000749	CcSEcCtD
Mirabegron—Dizziness—Propofol—epilepsy syndrome	5.17e-05	0.000748	CcSEcCtD
Mirabegron—Diarrhoea—Levetiracetam—epilepsy syndrome	5.17e-05	0.000748	CcSEcCtD
Mirabegron—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	5.16e-05	0.000747	CcSEcCtD
Mirabegron—Pruritus—Fosphenytoin—epilepsy syndrome	5.16e-05	0.000746	CcSEcCtD
Mirabegron—Dyspepsia—Lamotrigine—epilepsy syndrome	5.15e-05	0.000745	CcSEcCtD
Mirabegron—Erythema multiforme—Gabapentin—epilepsy syndrome	5.13e-05	0.000742	CcSEcCtD
Mirabegron—Asthenia—Vigabatrin—epilepsy syndrome	5.1e-05	0.000738	CcSEcCtD
Mirabegron—Infestation—Topiramate—epilepsy syndrome	5.09e-05	0.000736	CcSEcCtD
Mirabegron—Infestation NOS—Topiramate—epilepsy syndrome	5.09e-05	0.000736	CcSEcCtD
Mirabegron—Urticaria—Clonazepam—epilepsy syndrome	5.08e-05	0.000734	CcSEcCtD
Mirabegron—Eye disorder—Gabapentin—epilepsy syndrome	5.07e-05	0.000734	CcSEcCtD
Mirabegron—Dizziness—Midazolam—epilepsy syndrome	5.06e-05	0.000732	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	5.05e-05	0.000731	CcSEcCtD
Mirabegron—Abdominal pain—Clonazepam—epilepsy syndrome	5.05e-05	0.000731	CcSEcCtD
Mirabegron—Fatigue—Lamotrigine—epilepsy syndrome	5.05e-05	0.00073	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	5.04e-05	0.00073	CcSEcCtD
Mirabegron—Urticaria—Phenytoin—epilepsy syndrome	5.04e-05	0.000729	CcSEcCtD
Mirabegron—Cardiac disorder—Gabapentin—epilepsy syndrome	5.04e-05	0.000729	CcSEcCtD
Mirabegron—Palpitations—Valproic Acid—epilepsy syndrome	5.04e-05	0.000729	CcSEcCtD
Mirabegron—Pruritus—Vigabatrin—epilepsy syndrome	5.03e-05	0.000727	CcSEcCtD
Mirabegron—ORM1—central nervous system—epilepsy syndrome	5.03e-05	0.0292	CbGeAlD
Mirabegron—Asthenia—Diazepam—epilepsy syndrome	5.02e-05	0.000726	CcSEcCtD
Mirabegron—Urticaria—Oxcarbazepine—epilepsy syndrome	5.01e-05	0.000725	CcSEcCtD
Mirabegron—Constipation—Lamotrigine—epilepsy syndrome	5.01e-05	0.000724	CcSEcCtD
Mirabegron—Nausea—Acetazolamide—epilepsy syndrome	5e-05	0.000723	CcSEcCtD
Mirabegron—Dizziness—Levetiracetam—epilepsy syndrome	5e-05	0.000723	CcSEcCtD
Mirabegron—Abdominal pain—Oxcarbazepine—epilepsy syndrome	4.99e-05	0.000722	CcSEcCtD
Mirabegron—Diarrhoea—Fosphenytoin—epilepsy syndrome	4.99e-05	0.000722	CcSEcCtD
Mirabegron—Back pain—Pregabalin—epilepsy syndrome	4.98e-05	0.000721	CcSEcCtD
Mirabegron—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	4.95e-05	0.000717	CcSEcCtD
Mirabegron—Pruritus—Diazepam—epilepsy syndrome	4.95e-05	0.000716	CcSEcCtD
Mirabegron—Urinary tract infection—Topiramate—epilepsy syndrome	4.94e-05	0.000715	CcSEcCtD
Mirabegron—Rash—Propofol—epilepsy syndrome	4.93e-05	0.000713	CcSEcCtD
Mirabegron—Dermatitis—Propofol—epilepsy syndrome	4.93e-05	0.000713	CcSEcCtD
Mirabegron—Hypertension—Valproic Acid—epilepsy syndrome	4.92e-05	0.000712	CcSEcCtD
Mirabegron—Headache—Propofol—epilepsy syndrome	4.9e-05	0.000709	CcSEcCtD
Mirabegron—Diarrhoea—Vigabatrin—epilepsy syndrome	4.86e-05	0.000703	CcSEcCtD
Mirabegron—Asthenia—Felbamate—epilepsy syndrome	4.86e-05	0.000703	CcSEcCtD
Mirabegron—Vision blurred—Pregabalin—epilepsy syndrome	4.86e-05	0.000703	CcSEcCtD
Mirabegron—SLCO1A2—head—epilepsy syndrome	4.86e-05	0.0283	CbGeAlD
Mirabegron—Arthralgia—Valproic Acid—epilepsy syndrome	4.85e-05	0.000702	CcSEcCtD
Mirabegron—Rash—Midazolam—epilepsy syndrome	4.82e-05	0.000698	CcSEcCtD
Mirabegron—Dizziness—Fosphenytoin—epilepsy syndrome	4.82e-05	0.000697	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	4.82e-05	0.000697	CcSEcCtD
Mirabegron—Dermatitis—Midazolam—epilepsy syndrome	4.82e-05	0.000697	CcSEcCtD
Mirabegron—Urticaria—Carbamazepine—epilepsy syndrome	4.81e-05	0.000696	CcSEcCtD
Mirabegron—Headache—Midazolam—epilepsy syndrome	4.79e-05	0.000693	CcSEcCtD
Mirabegron—Pruritus—Felbamate—epilepsy syndrome	4.79e-05	0.000693	CcSEcCtD
Mirabegron—Abdominal pain—Carbamazepine—epilepsy syndrome	4.79e-05	0.000693	CcSEcCtD
Mirabegron—Diarrhoea—Diazepam—epilepsy syndrome	4.79e-05	0.000693	CcSEcCtD
Mirabegron—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	4.79e-05	0.000692	CcSEcCtD
Mirabegron—Sinusitis—Topiramate—epilepsy syndrome	4.77e-05	0.00069	CcSEcCtD
Mirabegron—Rash—Levetiracetam—epilepsy syndrome	4.76e-05	0.000689	CcSEcCtD
Mirabegron—Dermatitis—Levetiracetam—epilepsy syndrome	4.76e-05	0.000688	CcSEcCtD
Mirabegron—Asthenia—Zonisamide—epilepsy syndrome	4.76e-05	0.000688	CcSEcCtD
Mirabegron—Dry mouth—Valproic Acid—epilepsy syndrome	4.75e-05	0.000687	CcSEcCtD
Mirabegron—Headache—Levetiracetam—epilepsy syndrome	4.73e-05	0.000685	CcSEcCtD
Mirabegron—Propafenone—CYP2D6—epilepsy syndrome	4.71e-05	0.331	CrCbGaD
Mirabegron—Dizziness—Vigabatrin—epilepsy syndrome	4.7e-05	0.00068	CcSEcCtD
Mirabegron—Pruritus—Zonisamide—epilepsy syndrome	4.69e-05	0.000678	CcSEcCtD
Mirabegron—Urticaria—Lamotrigine—epilepsy syndrome	4.65e-05	0.000673	CcSEcCtD
Mirabegron—Nausea—Propofol—epilepsy syndrome	4.64e-05	0.000672	CcSEcCtD
Mirabegron—Diarrhoea—Felbamate—epilepsy syndrome	4.63e-05	0.00067	CcSEcCtD
Mirabegron—Abdominal pain—Lamotrigine—epilepsy syndrome	4.63e-05	0.000669	CcSEcCtD
Mirabegron—Dizziness—Diazepam—epilepsy syndrome	4.63e-05	0.000669	CcSEcCtD
Mirabegron—Infection—Valproic Acid—epilepsy syndrome	4.62e-05	0.000669	CcSEcCtD
Mirabegron—SLCO1A2—nervous system—epilepsy syndrome	4.6e-05	0.0268	CbGeAlD
Mirabegron—Rash—Fosphenytoin—epilepsy syndrome	4.6e-05	0.000665	CcSEcCtD
Mirabegron—Dermatitis—Fosphenytoin—epilepsy syndrome	4.59e-05	0.000664	CcSEcCtD
Mirabegron—Asthenia—Clonazepam—epilepsy syndrome	4.58e-05	0.000663	CcSEcCtD
Mirabegron—Rhinitis—Topiramate—epilepsy syndrome	4.58e-05	0.000662	CcSEcCtD
Mirabegron—Back pain—Gabapentin—epilepsy syndrome	4.57e-05	0.000661	CcSEcCtD
Mirabegron—Headache—Fosphenytoin—epilepsy syndrome	4.57e-05	0.000661	CcSEcCtD
Mirabegron—Palpitations—Pregabalin—epilepsy syndrome	4.55e-05	0.000659	CcSEcCtD
Mirabegron—Asthenia—Phenytoin—epilepsy syndrome	4.55e-05	0.000659	CcSEcCtD
Mirabegron—Nausea—Midazolam—epilepsy syndrome	4.54e-05	0.000657	CcSEcCtD
Mirabegron—Tachycardia—Valproic Acid—epilepsy syndrome	4.54e-05	0.000657	CcSEcCtD
Mirabegron—Diarrhoea—Zonisamide—epilepsy syndrome	4.54e-05	0.000656	CcSEcCtD
Mirabegron—Asthenia—Oxcarbazepine—epilepsy syndrome	4.53e-05	0.000655	CcSEcCtD
Mirabegron—Pruritus—Clonazepam—epilepsy syndrome	4.52e-05	0.000654	CcSEcCtD
Mirabegron—Skin disorder—Valproic Acid—epilepsy syndrome	4.52e-05	0.000654	CcSEcCtD
Mirabegron—Urinary tract disorder—Topiramate—epilepsy syndrome	4.51e-05	0.000652	CcSEcCtD
Mirabegron—Pruritus—Phenytoin—epilepsy syndrome	4.49e-05	0.000649	CcSEcCtD
Mirabegron—Connective tissue disorder—Topiramate—epilepsy syndrome	4.49e-05	0.000649	CcSEcCtD
Mirabegron—Nausea—Levetiracetam—epilepsy syndrome	4.49e-05	0.000649	CcSEcCtD
Mirabegron—Rash—Vigabatrin—epilepsy syndrome	4.48e-05	0.000648	CcSEcCtD
Mirabegron—Dizziness—Felbamate—epilepsy syndrome	4.48e-05	0.000648	CcSEcCtD
Mirabegron—Dermatitis—Vigabatrin—epilepsy syndrome	4.48e-05	0.000648	CcSEcCtD
Mirabegron—Urethral disorder—Topiramate—epilepsy syndrome	4.48e-05	0.000648	CcSEcCtD
Mirabegron—Pruritus—Oxcarbazepine—epilepsy syndrome	4.47e-05	0.000646	CcSEcCtD
Mirabegron—Vision blurred—Gabapentin—epilepsy syndrome	4.45e-05	0.000644	CcSEcCtD
Mirabegron—Headache—Vigabatrin—epilepsy syndrome	4.45e-05	0.000644	CcSEcCtD
Mirabegron—Hypertension—Pregabalin—epilepsy syndrome	4.45e-05	0.000644	CcSEcCtD
Mirabegron—SLCO1A2—central nervous system—epilepsy syndrome	4.43e-05	0.0258	CbGeAlD
Mirabegron—Rash—Diazepam—epilepsy syndrome	4.41e-05	0.000638	CcSEcCtD
Mirabegron—Dermatitis—Diazepam—epilepsy syndrome	4.41e-05	0.000638	CcSEcCtD
Mirabegron—Arthralgia—Pregabalin—epilepsy syndrome	4.39e-05	0.000635	CcSEcCtD
Mirabegron—Dizziness—Zonisamide—epilepsy syndrome	4.38e-05	0.000634	CcSEcCtD
Mirabegron—Headache—Diazepam—epilepsy syndrome	4.38e-05	0.000634	CcSEcCtD
Mirabegron—Diarrhoea—Clonazepam—epilepsy syndrome	4.37e-05	0.000632	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.36e-05	0.00063	CcSEcCtD
Mirabegron—Asthenia—Carbamazepine—epilepsy syndrome	4.35e-05	0.000629	CcSEcCtD
Mirabegron—Diarrhoea—Phenytoin—epilepsy syndrome	4.34e-05	0.000628	CcSEcCtD
Mirabegron—SLCO1A2—cerebellum—epilepsy syndrome	4.33e-05	0.0252	CbGeAlD
Mirabegron—Nausea—Fosphenytoin—epilepsy syndrome	4.33e-05	0.000626	CcSEcCtD
Mirabegron—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.32e-05	0.000625	CcSEcCtD
Mirabegron—Erythema multiforme—Topiramate—epilepsy syndrome	4.32e-05	0.000625	CcSEcCtD
Mirabegron—BCHE—medulla oblongata—epilepsy syndrome	4.31e-05	0.0251	CbGeAlD
Mirabegron—Dry mouth—Pregabalin—epilepsy syndrome	4.29e-05	0.000621	CcSEcCtD
Mirabegron—Pruritus—Carbamazepine—epilepsy syndrome	4.29e-05	0.00062	CcSEcCtD
Mirabegron—Rash—Felbamate—epilepsy syndrome	4.27e-05	0.000618	CcSEcCtD
Mirabegron—Eye disorder—Topiramate—epilepsy syndrome	4.27e-05	0.000617	CcSEcCtD
Mirabegron—Dermatitis—Felbamate—epilepsy syndrome	4.27e-05	0.000617	CcSEcCtD
Mirabegron—Headache—Felbamate—epilepsy syndrome	4.24e-05	0.000614	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.24e-05	0.000613	CcSEcCtD
Mirabegron—Cardiac disorder—Topiramate—epilepsy syndrome	4.24e-05	0.000613	CcSEcCtD
Mirabegron—Dizziness—Clonazepam—epilepsy syndrome	4.22e-05	0.000611	CcSEcCtD
Mirabegron—Nausea—Vigabatrin—epilepsy syndrome	4.22e-05	0.000611	CcSEcCtD
Mirabegron—Asthenia—Lamotrigine—epilepsy syndrome	4.2e-05	0.000608	CcSEcCtD
Mirabegron—Dizziness—Phenytoin—epilepsy syndrome	4.2e-05	0.000607	CcSEcCtD
Mirabegron—Rash—Zonisamide—epilepsy syndrome	4.18e-05	0.000605	CcSEcCtD
Mirabegron—Infection—Pregabalin—epilepsy syndrome	4.18e-05	0.000604	CcSEcCtD
Mirabegron—Palpitations—Gabapentin—epilepsy syndrome	4.18e-05	0.000604	CcSEcCtD
Mirabegron—Dermatitis—Zonisamide—epilepsy syndrome	4.18e-05	0.000604	CcSEcCtD
Mirabegron—Dizziness—Oxcarbazepine—epilepsy syndrome	4.17e-05	0.000604	CcSEcCtD
Mirabegron—Nausea—Diazepam—epilepsy syndrome	4.16e-05	0.000601	CcSEcCtD
Mirabegron—Headache—Zonisamide—epilepsy syndrome	4.15e-05	0.000601	CcSEcCtD
Mirabegron—Diarrhoea—Carbamazepine—epilepsy syndrome	4.14e-05	0.0006	CcSEcCtD
Mirabegron—Pruritus—Lamotrigine—epilepsy syndrome	4.14e-05	0.000599	CcSEcCtD
Mirabegron—Tachycardia—Pregabalin—epilepsy syndrome	4.1e-05	0.000594	CcSEcCtD
Mirabegron—Dyspepsia—Valproic Acid—epilepsy syndrome	4.1e-05	0.000592	CcSEcCtD
Mirabegron—CYP2D6—brainstem—epilepsy syndrome	4.09e-05	0.0238	CbGeAlD
Mirabegron—Skin disorder—Pregabalin—epilepsy syndrome	4.09e-05	0.000591	CcSEcCtD
Mirabegron—Hypertension—Gabapentin—epilepsy syndrome	4.08e-05	0.00059	CcSEcCtD
Mirabegron—Rash—Clonazepam—epilepsy syndrome	4.03e-05	0.000583	CcSEcCtD
Mirabegron—Dermatitis—Clonazepam—epilepsy syndrome	4.02e-05	0.000582	CcSEcCtD
Mirabegron—Arthralgia—Gabapentin—epilepsy syndrome	4.02e-05	0.000582	CcSEcCtD
Mirabegron—Nausea—Felbamate—epilepsy syndrome	4.02e-05	0.000582	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.02e-05	0.000581	CcSEcCtD
Mirabegron—Fatigue—Valproic Acid—epilepsy syndrome	4.01e-05	0.00058	CcSEcCtD
Mirabegron—Dizziness—Carbamazepine—epilepsy syndrome	4.01e-05	0.000579	CcSEcCtD
Mirabegron—Diarrhoea—Lamotrigine—epilepsy syndrome	4.01e-05	0.000579	CcSEcCtD
Mirabegron—Headache—Clonazepam—epilepsy syndrome	4e-05	0.000579	CcSEcCtD
Mirabegron—Rash—Phenytoin—epilepsy syndrome	4e-05	0.000579	CcSEcCtD
Mirabegron—Dermatitis—Phenytoin—epilepsy syndrome	4e-05	0.000578	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4e-05	0.000578	CcSEcCtD
Mirabegron—Rash—Oxcarbazepine—epilepsy syndrome	3.98e-05	0.000576	CcSEcCtD
Mirabegron—Constipation—Valproic Acid—epilepsy syndrome	3.98e-05	0.000575	CcSEcCtD
Mirabegron—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.98e-05	0.000575	CcSEcCtD
Mirabegron—Headache—Phenytoin—epilepsy syndrome	3.98e-05	0.000575	CcSEcCtD
Mirabegron—Headache—Oxcarbazepine—epilepsy syndrome	3.95e-05	0.000572	CcSEcCtD
Mirabegron—CYP2D6—forebrain—epilepsy syndrome	3.95e-05	0.023	CbGeAlD
Mirabegron—Nausea—Zonisamide—epilepsy syndrome	3.94e-05	0.00057	CcSEcCtD
Mirabegron—BCHE—midbrain—epilepsy syndrome	3.94e-05	0.0229	CbGeAlD
Mirabegron—Dry mouth—Gabapentin—epilepsy syndrome	3.93e-05	0.000569	CcSEcCtD
Mirabegron—Dizziness—Lamotrigine—epilepsy syndrome	3.87e-05	0.00056	CcSEcCtD
Mirabegron—Back pain—Topiramate—epilepsy syndrome	3.85e-05	0.000556	CcSEcCtD
Mirabegron—BCHE—spinal cord—epilepsy syndrome	3.84e-05	0.0224	CbGeAlD
Mirabegron—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.83e-05	0.000554	CcSEcCtD
Mirabegron—Infection—Gabapentin—epilepsy syndrome	3.83e-05	0.000554	CcSEcCtD
Mirabegron—Rash—Carbamazepine—epilepsy syndrome	3.82e-05	0.000552	CcSEcCtD
Mirabegron—Dermatitis—Carbamazepine—epilepsy syndrome	3.82e-05	0.000552	CcSEcCtD
Mirabegron—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.8e-05	0.00055	CcSEcCtD
Mirabegron—Nausea—Clonazepam—epilepsy syndrome	3.79e-05	0.000549	CcSEcCtD
Mirabegron—Headache—Carbamazepine—epilepsy syndrome	3.79e-05	0.000549	CcSEcCtD
Mirabegron—Nausea—Phenytoin—epilepsy syndrome	3.77e-05	0.000545	CcSEcCtD
Mirabegron—Tachycardia—Gabapentin—epilepsy syndrome	3.76e-05	0.000544	CcSEcCtD
Mirabegron—Nausea—Oxcarbazepine—epilepsy syndrome	3.75e-05	0.000542	CcSEcCtD
Mirabegron—Vision blurred—Topiramate—epilepsy syndrome	3.75e-05	0.000542	CcSEcCtD
Mirabegron—Skin disorder—Gabapentin—epilepsy syndrome	3.75e-05	0.000542	CcSEcCtD
Mirabegron—Urticaria—Valproic Acid—epilepsy syndrome	3.7e-05	0.000535	CcSEcCtD
Mirabegron—Rash—Lamotrigine—epilepsy syndrome	3.69e-05	0.000534	CcSEcCtD
Mirabegron—Dermatitis—Lamotrigine—epilepsy syndrome	3.69e-05	0.000533	CcSEcCtD
Mirabegron—Abdominal pain—Valproic Acid—epilepsy syndrome	3.68e-05	0.000532	CcSEcCtD
Mirabegron—Headache—Lamotrigine—epilepsy syndrome	3.67e-05	0.000531	CcSEcCtD
Mirabegron—CYP2D6—telencephalon—epilepsy syndrome	3.63e-05	0.0211	CbGeAlD
Mirabegron—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.63e-05	0.000525	CcSEcCtD
Mirabegron—Fatigue—Pregabalin—epilepsy syndrome	3.63e-05	0.000525	CcSEcCtD
Mirabegron—Nausea—Carbamazepine—epilepsy syndrome	3.6e-05	0.00052	CcSEcCtD
Mirabegron—Constipation—Pregabalin—epilepsy syndrome	3.6e-05	0.00052	CcSEcCtD
Mirabegron—SLCO1A2—brain—epilepsy syndrome	3.52e-05	0.0205	CbGeAlD
Mirabegron—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.51e-05	0.000508	CcSEcCtD
Mirabegron—Palpitations—Topiramate—epilepsy syndrome	3.51e-05	0.000508	CcSEcCtD
Mirabegron—ALB—brain—epilepsy syndrome	3.5e-05	0.0204	CbGeAlD
Mirabegron—Nausea—Lamotrigine—epilepsy syndrome	3.48e-05	0.000503	CcSEcCtD
Mirabegron—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.44e-05	0.000497	CcSEcCtD
Mirabegron—Hypertension—Topiramate—epilepsy syndrome	3.43e-05	0.000496	CcSEcCtD
Mirabegron—BCHE—head—epilepsy syndrome	3.41e-05	0.0199	CbGeAlD
Mirabegron—Dyspepsia—Gabapentin—epilepsy syndrome	3.39e-05	0.000491	CcSEcCtD
Mirabegron—Arthralgia—Topiramate—epilepsy syndrome	3.38e-05	0.00049	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.36e-05	0.000486	CcSEcCtD
Mirabegron—Propafenone—ABCB1—epilepsy syndrome	3.36e-05	0.236	CrCbGaD
Mirabegron—Urticaria—Pregabalin—epilepsy syndrome	3.34e-05	0.000483	CcSEcCtD
Mirabegron—Asthenia—Valproic Acid—epilepsy syndrome	3.34e-05	0.000483	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.33e-05	0.000482	CcSEcCtD
Mirabegron—Fatigue—Gabapentin—epilepsy syndrome	3.32e-05	0.000481	CcSEcCtD
Mirabegron—Abdominal pain—Pregabalin—epilepsy syndrome	3.32e-05	0.000481	CcSEcCtD
Mirabegron—Dry mouth—Topiramate—epilepsy syndrome	3.31e-05	0.000479	CcSEcCtD
Mirabegron—Constipation—Gabapentin—epilepsy syndrome	3.3e-05	0.000477	CcSEcCtD
Mirabegron—Pruritus—Valproic Acid—epilepsy syndrome	3.29e-05	0.000476	CcSEcCtD
Mirabegron—BCHE—nervous system—epilepsy syndrome	3.24e-05	0.0188	CbGeAlD
Mirabegron—Infection—Topiramate—epilepsy syndrome	3.22e-05	0.000466	CcSEcCtD
Mirabegron—Diarrhoea—Valproic Acid—epilepsy syndrome	3.18e-05	0.00046	CcSEcCtD
Mirabegron—Tachycardia—Topiramate—epilepsy syndrome	3.17e-05	0.000458	CcSEcCtD
Mirabegron—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.15e-05	0.000456	CcSEcCtD
Mirabegron—Skin disorder—Topiramate—epilepsy syndrome	3.15e-05	0.000456	CcSEcCtD
Mirabegron—BCHE—central nervous system—epilepsy syndrome	3.12e-05	0.0181	CbGeAlD
Mirabegron—Dizziness—Valproic Acid—epilepsy syndrome	3.08e-05	0.000445	CcSEcCtD
Mirabegron—Urticaria—Gabapentin—epilepsy syndrome	3.06e-05	0.000443	CcSEcCtD
Mirabegron—Abdominal pain—Gabapentin—epilepsy syndrome	3.05e-05	0.000441	CcSEcCtD
Mirabegron—BCHE—cerebellum—epilepsy syndrome	3.05e-05	0.0177	CbGeAlD
Mirabegron—Asthenia—Pregabalin—epilepsy syndrome	3.02e-05	0.000436	CcSEcCtD
Mirabegron—Pruritus—Pregabalin—epilepsy syndrome	2.98e-05	0.00043	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.96e-05	0.000428	CcSEcCtD
Mirabegron—Rash—Valproic Acid—epilepsy syndrome	2.93e-05	0.000424	CcSEcCtD
Mirabegron—Dermatitis—Valproic Acid—epilepsy syndrome	2.93e-05	0.000424	CcSEcCtD
Mirabegron—Headache—Valproic Acid—epilepsy syndrome	2.91e-05	0.000422	CcSEcCtD
Mirabegron—Diarrhoea—Pregabalin—epilepsy syndrome	2.88e-05	0.000416	CcSEcCtD
Mirabegron—Dyspepsia—Topiramate—epilepsy syndrome	2.86e-05	0.000413	CcSEcCtD
Mirabegron—ABCB1—forebrain—epilepsy syndrome	2.84e-05	0.0165	CbGeAlD
Mirabegron—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.8e-05	0.000405	CcSEcCtD
Mirabegron—Fatigue—Topiramate—epilepsy syndrome	2.8e-05	0.000405	CcSEcCtD
Mirabegron—Dizziness—Pregabalin—epilepsy syndrome	2.78e-05	0.000402	CcSEcCtD
Mirabegron—Constipation—Topiramate—epilepsy syndrome	2.77e-05	0.000401	CcSEcCtD
Mirabegron—Asthenia—Gabapentin—epilepsy syndrome	2.77e-05	0.0004	CcSEcCtD
Mirabegron—Nausea—Valproic Acid—epilepsy syndrome	2.76e-05	0.0004	CcSEcCtD
Mirabegron—Pruritus—Gabapentin—epilepsy syndrome	2.73e-05	0.000395	CcSEcCtD
Mirabegron—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.65e-05	0.000384	CcSEcCtD
Mirabegron—Rash—Pregabalin—epilepsy syndrome	2.65e-05	0.000384	CcSEcCtD
Mirabegron—Dermatitis—Pregabalin—epilepsy syndrome	2.65e-05	0.000383	CcSEcCtD
Mirabegron—Diarrhoea—Gabapentin—epilepsy syndrome	2.64e-05	0.000382	CcSEcCtD
Mirabegron—Headache—Pregabalin—epilepsy syndrome	2.63e-05	0.000381	CcSEcCtD
Mirabegron—ABCB1—telencephalon—epilepsy syndrome	2.61e-05	0.0152	CbGeAlD
Mirabegron—Urticaria—Topiramate—epilepsy syndrome	2.58e-05	0.000373	CcSEcCtD
Mirabegron—Abdominal pain—Topiramate—epilepsy syndrome	2.56e-05	0.000371	CcSEcCtD
Mirabegron—Dizziness—Gabapentin—epilepsy syndrome	2.55e-05	0.000369	CcSEcCtD
Mirabegron—Nausea—Pregabalin—epilepsy syndrome	2.5e-05	0.000361	CcSEcCtD
Mirabegron—BCHE—brain—epilepsy syndrome	2.47e-05	0.0144	CbGeAlD
Mirabegron—Rash—Gabapentin—epilepsy syndrome	2.43e-05	0.000352	CcSEcCtD
Mirabegron—Dermatitis—Gabapentin—epilepsy syndrome	2.43e-05	0.000351	CcSEcCtD
Mirabegron—Headache—Gabapentin—epilepsy syndrome	2.42e-05	0.000349	CcSEcCtD
Mirabegron—Asthenia—Topiramate—epilepsy syndrome	2.33e-05	0.000337	CcSEcCtD
Mirabegron—Pruritus—Topiramate—epilepsy syndrome	2.3e-05	0.000332	CcSEcCtD
Mirabegron—Nausea—Gabapentin—epilepsy syndrome	2.29e-05	0.000331	CcSEcCtD
Mirabegron—CYP2D6—head—epilepsy syndrome	2.26e-05	0.0132	CbGeAlD
Mirabegron—Diarrhoea—Topiramate—epilepsy syndrome	2.22e-05	0.000321	CcSEcCtD
Mirabegron—CYP3A4—nervous system—epilepsy syndrome	2.18e-05	0.0127	CbGeAlD
Mirabegron—Dizziness—Topiramate—epilepsy syndrome	2.15e-05	0.00031	CcSEcCtD
Mirabegron—CYP2D6—nervous system—epilepsy syndrome	2.14e-05	0.0125	CbGeAlD
Mirabegron—CYP3A4—central nervous system—epilepsy syndrome	2.1e-05	0.0122	CbGeAlD
Mirabegron—CYP2D6—central nervous system—epilepsy syndrome	2.06e-05	0.012	CbGeAlD
Mirabegron—ABCB1—medulla oblongata—epilepsy syndrome	2.05e-05	0.0119	CbGeAlD
Mirabegron—Rash—Topiramate—epilepsy syndrome	2.05e-05	0.000296	CcSEcCtD
Mirabegron—Dermatitis—Topiramate—epilepsy syndrome	2.04e-05	0.000296	CcSEcCtD
Mirabegron—Headache—Topiramate—epilepsy syndrome	2.03e-05	0.000294	CcSEcCtD
Mirabegron—CYP2D6—cerebellum—epilepsy syndrome	2.02e-05	0.0117	CbGeAlD
Mirabegron—Nausea—Topiramate—epilepsy syndrome	1.93e-05	0.000279	CcSEcCtD
Mirabegron—ABCB1—midbrain—epilepsy syndrome	1.88e-05	0.0109	CbGeAlD
Mirabegron—ABCB1—spinal cord—epilepsy syndrome	1.83e-05	0.0107	CbGeAlD
Mirabegron—CYP2D6—brain—epilepsy syndrome	1.64e-05	0.00954	CbGeAlD
Mirabegron—ABCB1—head—epilepsy syndrome	1.63e-05	0.00947	CbGeAlD
Mirabegron—ABCB1—nervous system—epilepsy syndrome	1.54e-05	0.00898	CbGeAlD
Mirabegron—ABCB1—central nervous system—epilepsy syndrome	1.48e-05	0.00864	CbGeAlD
Mirabegron—ABCB1—cerebellum—epilepsy syndrome	1.45e-05	0.00845	CbGeAlD
Mirabegron—ABCB1—brain—epilepsy syndrome	1.18e-05	0.00686	CbGeAlD
Mirabegron—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	4.84e-06	0.000167	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—CDC42—epilepsy syndrome	4.76e-06	0.000164	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	4.72e-06	0.000163	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CACNA1A—epilepsy syndrome	4.69e-06	0.000162	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ALDH7A1—epilepsy syndrome	4.69e-06	0.000162	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—SLC2A1—epilepsy syndrome	4.69e-06	0.000162	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	4.67e-06	0.000161	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PLCB1—epilepsy syndrome	4.64e-06	0.00016	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—S100B—epilepsy syndrome	4.64e-06	0.00016	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PDXK—epilepsy syndrome	4.62e-06	0.00016	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—FAR1—epilepsy syndrome	4.62e-06	0.00016	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ADK—epilepsy syndrome	4.62e-06	0.00016	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	4.62e-06	0.00016	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CERS1—epilepsy syndrome	4.62e-06	0.00016	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	4.62e-06	0.00016	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—TH—epilepsy syndrome	4.62e-06	0.00016	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SOCS3—epilepsy syndrome	4.59e-06	0.000159	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ST3GAL3—epilepsy syndrome	4.59e-06	0.000159	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CDC42—epilepsy syndrome	4.58e-06	0.000158	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.57e-06	0.000158	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GBE1—epilepsy syndrome	4.56e-06	0.000157	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	4.56e-06	0.000157	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.55e-06	0.000157	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP2D6—epilepsy syndrome	4.55e-06	0.000157	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ASAH1—epilepsy syndrome	4.55e-06	0.000157	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ADSL—epilepsy syndrome	4.5e-06	0.000155	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	4.5e-06	0.000155	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AVP—epilepsy syndrome	4.44e-06	0.000153	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—STXBP1—epilepsy syndrome	4.42e-06	0.000153	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GLUL—epilepsy syndrome	4.41e-06	0.000152	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ADRA2A—epilepsy syndrome	4.33e-06	0.00015	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	4.33e-06	0.00015	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CACNA1D—epilepsy syndrome	4.33e-06	0.00015	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—POMC—epilepsy syndrome	4.33e-06	0.000149	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NT5E—epilepsy syndrome	4.31e-06	0.000149	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALAD—epilepsy syndrome	4.31e-06	0.000149	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.29e-06	0.000148	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	4.29e-06	0.000148	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—FYN—epilepsy syndrome	4.24e-06	0.000146	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—CCL2—epilepsy syndrome	4.23e-06	0.000146	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	4.23e-06	0.000146	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	4.23e-06	0.000146	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PNPO—epilepsy syndrome	4.23e-06	0.000146	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GAMT—epilepsy syndrome	4.23e-06	0.000146	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	4.21e-06	0.000145	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HES1—epilepsy syndrome	4.2e-06	0.000145	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	4.17e-06	0.000144	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—SLC2A1—epilepsy syndrome	4.12e-06	0.000142	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	4.11e-06	0.000142	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	4.11e-06	0.000142	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FYN—epilepsy syndrome	4.08e-06	0.000141	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—YWHAZ—epilepsy syndrome	4.07e-06	0.000141	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PLCB1—epilepsy syndrome	4.07e-06	0.000141	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—H2AFX—epilepsy syndrome	4.07e-06	0.00014	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NT5E—epilepsy syndrome	4.06e-06	0.00014	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALAD—epilepsy syndrome	4.06e-06	0.00014	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MEF2C—epilepsy syndrome	4.06e-06	0.00014	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—TH—epilepsy syndrome	4.06e-06	0.00014	CbGpPWpGaD
Mirabegron—ALB—Metabolism—TXNRD1—epilepsy syndrome	4.05e-06	0.00014	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.03e-06	0.000139	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	4.03e-06	0.000139	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.99e-06	0.000138	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.99e-06	0.000138	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ADSL—epilepsy syndrome	3.94e-06	0.000136	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AQP1—epilepsy syndrome	3.93e-06	0.000136	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—QDPR—epilepsy syndrome	3.93e-06	0.000136	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CA4—epilepsy syndrome	3.93e-06	0.000136	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—YWHAZ—epilepsy syndrome	3.92e-06	0.000135	CbGpPWpGaD
Mirabegron—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	3.92e-06	0.000135	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NGF—epilepsy syndrome	3.88e-06	0.000134	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	3.88e-06	0.000134	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	3.88e-06	0.000134	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GLUL—epilepsy syndrome	3.87e-06	0.000133	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.86e-06	0.000133	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—HMOX1—epilepsy syndrome	3.86e-06	0.000133	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	3.83e-06	0.000132	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CAT—epilepsy syndrome	3.81e-06	0.000131	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	3.8e-06	0.000131	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	3.79e-06	0.000131	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.78e-06	0.00013	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	3.77e-06	0.00013	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CCR5—epilepsy syndrome	3.77e-06	0.00013	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	3.73e-06	0.000129	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ADSL—epilepsy syndrome	3.72e-06	0.000128	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ABCB1—epilepsy syndrome	3.7e-06	0.000128	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—COX3—epilepsy syndrome	3.7e-06	0.000128	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HTR2A—epilepsy syndrome	3.69e-06	0.000127	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	3.68e-06	0.000127	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GLUL—epilepsy syndrome	3.64e-06	0.000126	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PLAU—epilepsy syndrome	3.62e-06	0.000125	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	3.58e-06	0.000123	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CHRM3—epilepsy syndrome	3.56e-06	0.000123	CbGpPWpGaD
Mirabegron—ALB—Metabolism—KCNJ11—epilepsy syndrome	3.56e-06	0.000123	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	3.55e-06	0.000123	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.53e-06	0.000122	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TSC2—epilepsy syndrome	3.51e-06	0.000121	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.5e-06	0.000121	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.5e-06	0.000121	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.5e-06	0.000121	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.5e-06	0.000121	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.5e-06	0.000121	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AGT—epilepsy syndrome	3.5e-06	0.000121	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.5e-06	0.000121	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AQP1—epilepsy syndrome	3.45e-06	0.000119	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GPX1—epilepsy syndrome	3.44e-06	0.000119	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—APOE—epilepsy syndrome	3.43e-06	0.000118	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—HMOX1—epilepsy syndrome	3.39e-06	0.000117	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—KDR—epilepsy syndrome	3.36e-06	0.000116	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PRKCB—epilepsy syndrome	3.36e-06	0.000116	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	3.35e-06	0.000115	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CAT—epilepsy syndrome	3.34e-06	0.000115	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—NOS2—epilepsy syndrome	3.32e-06	0.000115	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.31e-06	0.000114	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ABCB1—epilepsy syndrome	3.25e-06	0.000112	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AQP1—epilepsy syndrome	3.25e-06	0.000112	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.25e-06	0.000112	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PRKCB—epilepsy syndrome	3.24e-06	0.000112	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6ST—epilepsy syndrome	3.22e-06	0.000111	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.21e-06	0.000111	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.21e-06	0.000111	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.21e-06	0.000111	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.15e-06	0.000109	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CHRM3—epilepsy syndrome	3.12e-06	0.000108	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	3.12e-06	0.000108	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.09e-06	0.000107	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GPX1—epilepsy syndrome	3.02e-06	0.000104	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—AGT—epilepsy syndrome	3.02e-06	0.000104	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.98e-06	0.000103	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.98e-06	0.000103	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—APOE—epilepsy syndrome	2.96e-06	0.000102	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—POMC—epilepsy syndrome	2.95e-06	0.000102	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	2.94e-06	0.000101	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	2.94e-06	0.000101	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ABCG2—epilepsy syndrome	2.9e-06	0.0001	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CCL2—epilepsy syndrome	2.89e-06	9.96e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP2C19—epilepsy syndrome	2.83e-06	9.75e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP11A1—epilepsy syndrome	2.81e-06	9.69e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.8e-06	9.67e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.79e-06	9.62e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.73e-06	9.41e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.66e-06	9.17e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.66e-06	9.17e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AGT—epilepsy syndrome	2.65e-06	9.14e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FGF2—epilepsy syndrome	2.61e-06	9e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—APOE—epilepsy syndrome	2.6e-06	8.96e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—POMC—epilepsy syndrome	2.54e-06	8.77e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ABCG2—epilepsy syndrome	2.54e-06	8.77e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP2D6—epilepsy syndrome	2.53e-06	8.75e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.53e-06	8.75e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.53e-06	8.75e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.48e-06	8.56e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	2.48e-06	8.55e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.46e-06	8.49e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.43e-06	8.38e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—RELA—epilepsy syndrome	2.42e-06	8.35e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ADRA2A—epilepsy syndrome	2.41e-06	8.33e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—BCHE—epilepsy syndrome	2.4e-06	8.29e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.39e-06	8.26e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.38e-06	8.22e-05	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	2.38e-06	8.22e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MTOR—epilepsy syndrome	2.37e-06	8.19e-05	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.35e-06	8.1e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.34e-06	8.07e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.33e-06	8.05e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.32e-06	8e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ALB—epilepsy syndrome	2.32e-06	8e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SLC2A1—epilepsy syndrome	2.29e-06	7.91e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PLCB1—epilepsy syndrome	2.27e-06	7.83e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—TH—epilepsy syndrome	2.26e-06	7.8e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—POMC—epilepsy syndrome	2.23e-06	7.7e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.22e-06	7.68e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.22e-06	7.67e-05	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.2e-06	7.61e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.19e-06	7.55e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CASP3—epilepsy syndrome	2.18e-06	7.54e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.12e-06	7.33e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—JUN—epilepsy syndrome	2.12e-06	7.32e-05	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.12e-06	7.31e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.11e-06	7.3e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.11e-06	7.27e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MMP9—epilepsy syndrome	2.06e-06	7.12e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ALB—epilepsy syndrome	2.03e-06	7.02e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTGS2—epilepsy syndrome	2.03e-06	7e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.01e-06	6.93e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—AKT1—epilepsy syndrome	2e-06	6.91e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.99e-06	6.88e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.99e-06	6.86e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.98e-06	6.85e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—TH—epilepsy syndrome	1.98e-06	6.83e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—SRC—epilepsy syndrome	1.98e-06	6.82e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—VEGFA—epilepsy syndrome	1.92e-06	6.64e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.92e-06	6.63e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.92e-06	6.63e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SRC—epilepsy syndrome	1.9e-06	6.57e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.89e-06	6.53e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HMOX1—epilepsy syndrome	1.89e-06	6.51e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.87e-06	6.46e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—TH—epilepsy syndrome	1.87e-06	6.44e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CAT—epilepsy syndrome	1.86e-06	6.42e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—VEGFA—epilepsy syndrome	1.85e-06	6.39e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ABCB1—epilepsy syndrome	1.81e-06	6.25e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS2—epilepsy syndrome	1.78e-06	6.14e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GPX1—epilepsy syndrome	1.68e-06	5.81e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.65e-06	5.7e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CAT—epilepsy syndrome	1.63e-06	5.63e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.57e-06	5.4e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.56e-06	5.37e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.54e-06	5.3e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.53e-06	5.27e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.52e-06	5.23e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.49e-06	5.16e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AGT—epilepsy syndrome	1.48e-06	5.09e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.47e-06	5.09e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOE—epilepsy syndrome	1.45e-06	4.99e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.39e-06	4.79e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.37e-06	4.72e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.3e-06	4.5e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.3e-06	4.48e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AGT—epilepsy syndrome	1.29e-06	4.46e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOE—epilepsy syndrome	1.27e-06	4.37e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—POMC—epilepsy syndrome	1.24e-06	4.29e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.24e-06	4.27e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—AKT1—epilepsy syndrome	1.23e-06	4.24e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.22e-06	4.22e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TH—epilepsy syndrome	1.22e-06	4.21e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.22e-06	4.2e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.19e-06	4.12e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AKT1—epilepsy syndrome	1.18e-06	4.08e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—POMC—epilepsy syndrome	1.09e-06	3.76e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.03e-06	3.54e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—AKT1—epilepsy syndrome	1.02e-06	3.52e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.02e-06	3.51e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CAT—epilepsy syndrome	1e-06	3.47e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALB—epilepsy syndrome	9.92e-07	3.42e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS2—epilepsy syndrome	9.91e-07	3.42e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	9.77e-07	3.37e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALB—epilepsy syndrome	9.35e-07	3.23e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GPX1—epilepsy syndrome	9.08e-07	3.13e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AKT1—epilepsy syndrome	8.94e-07	3.09e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS2—epilepsy syndrome	8.68e-07	3e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	8.18e-07	2.82e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AGT—epilepsy syndrome	7.96e-07	2.75e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOE—epilepsy syndrome	7.8e-07	2.69e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.7e-07	2.31e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.11e-07	2.11e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.35e-07	1.85e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AKT1—epilepsy syndrome	4.98e-07	1.72e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AKT1—epilepsy syndrome	4.36e-07	1.51e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AKT1—epilepsy syndrome	4.11e-07	1.42e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.69e-07	9.28e-06	CbGpPWpGaD
